109 related articles for article (PubMed ID: 12510790)
41. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effects of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z).
Slavin S; Mumcuoglu M; Landesberg-Weisz A; Kedar E
Bone Marrow Transplant; 1989 Sep; 4(5):459-64. PubMed ID: 2676042
[TBL] [Abstract][Full Text] [Related]
42. Chronic alcohol consumption perturbs the balance between thymus-derived and bone marrow-derived natural killer cells in the spleen.
Zhang H; Meadows GG
J Leukoc Biol; 2008 Jan; 83(1):41-7. PubMed ID: 17906116
[TBL] [Abstract][Full Text] [Related]
43. The relationship between different high proliferative potential colony-forming cells in mouse bone marrow.
Kriegler AB; Verschoor SM; Bernardo D; Bertoncello I
Exp Hematol; 1994 May; 22(5):432-40. PubMed ID: 7513652
[TBL] [Abstract][Full Text] [Related]
44. Synergy between recombinant human IL-1 alpha (rHuIL-1) and M-CSF (rHuM-CSF) during the recovery of murine hematopoietic activity in myelosuppressed animals: abbreviated versus chronic administration of rHuM-CSF.
Kovacs CJ; Harrell JP; Gooya JM; Evans MJ; Johnke RM
Exp Hematol; 1992 Jun; 20(5):582-9. PubMed ID: 1587305
[TBL] [Abstract][Full Text] [Related]
45. In vitro and in vivo cytokine-induced facilitation of immunohematopoietic reconstitution in mice undergoing bone marrow transplantation.
Kedar E; Tsuberi BZ; Landesberg A; Anafi M; Leshem B; Gillis S; Urdal DL; Slavin S
Bone Marrow Transplant; 1988 Jul; 3(4):297-314. PubMed ID: 3048495
[TBL] [Abstract][Full Text] [Related]
46. Comparative analysis of murine dendritic cells derived from spleen and bone marrow.
Fields RC; Osterholzer JJ; Fuller JA; Thomas EK; Geraghty PJ; Mulé JJ
J Immunother; 1998 Sep; 21(5):323-39. PubMed ID: 9789195
[TBL] [Abstract][Full Text] [Related]
47. Synergistic effects of granulocyte-colony stimulating factor and macrophage-colony stimulating factor on recovery of donor hematopoietic cells in allogeneic bone marrow transplantation.
Zhang Y; Adachi Y; Suzuki Y; Minamino K; Iwasaki M; Nakano K; Koike Y; Mukaide H; Shigematsu A; Kiriyama N; Li C; Ikehara S
Oncol Rep; 2006 Aug; 16(2):367-71. PubMed ID: 16820917
[TBL] [Abstract][Full Text] [Related]
48. Stem cell responses in myelosuppressed mice following sequential treatment with recombinant human interleukin 1 (rHuIL-1), recombinant murine interleukin 3 (rMuIL-3) and recombinant human macrophage colony-stimulating factor (rHuM-CSF).
Kovacs CJ; Harrell JP; Evans MJ; Abernathy RS; Roberts CJ; Johnke RM
Stem Cells; 1994 Jan; 12(1):103-13. PubMed ID: 8142915
[TBL] [Abstract][Full Text] [Related]
49. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.
Gazzola MV; Collins NH; Tafuri A; Keever CA
Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965
[TBL] [Abstract][Full Text] [Related]
50. Expression of M-CSF and its receptor (C-FMS) during factor-independent cell line evolution from hematopoietic progenitor cells cocultivated with gamma irradiated marrow stromal cell lines.
Greenberger JS; Sakakeeny MA; Leif J; Anklesaria P; Pierce JH; Shadduck RK
Leukemia; 1992 Jul; 6(7):626-33. PubMed ID: 1385639
[TBL] [Abstract][Full Text] [Related]
51. Down-regulation of osteoprotegerin production in bone marrow macrophages by macrophage colony-stimulating factor.
Yamada N; Tsujimura T; Ueda H; Hayashi S; Ohyama H; Okamura H; Terada N
Cytokine; 2005 Aug; 31(4):288-97. PubMed ID: 15996478
[TBL] [Abstract][Full Text] [Related]
52. Generation of mouse natural killer (NK) cell activity: effect of interleukin-2 (IL-2) and interferon (IFN) on the in vivo development of natural killer cells from bone marrow (BM) progenitor cells.
Riccardi C; Giampietri A; Migliorati G; Cannarile L; D'Adamio L; Herberman RB
Int J Cancer; 1986 Oct; 38(4):553-62. PubMed ID: 2944847
[TBL] [Abstract][Full Text] [Related]
53. Progenitor cells in murine bone marrow stimulated by growth factors produced by the AF1-19T rat cell line.
Kriegler AB; Bradley TR; Bertoncello I; Hamilton JA; Hart PH; Piccoli DS; Hodgson GS
Exp Hematol; 1990 Jun; 18(5):372-8. PubMed ID: 2186922
[TBL] [Abstract][Full Text] [Related]
54. Effect in vivo of multiple injections of purified murine and recombinant human macrophage colony-stimulating factor to mice.
Chikkappa G; Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Greenberg ML; Waheed A; Shadduck RK
Cancer Res; 1989 Jul; 49(13):3558-61. PubMed ID: 2659162
[TBL] [Abstract][Full Text] [Related]
55. A critical role for IL-18 in the proliferation and activation of NK1.1+ CD3- cells.
Tomura M; Zhou XY; Maruo S; Ahn HJ; Hamaoka T; Okamura H; Nakanishi K; Tanimoto T; Kurimoto M; Fujiwara H
J Immunol; 1998 May; 160(10):4738-46. PubMed ID: 9590219
[TBL] [Abstract][Full Text] [Related]
56. Bone marrow-derived macrophages grown in GM-CSF or M-CSF differ in their ability to produce IL-12 and to induce IFN-gamma production after stimulation with Trypanosoma cruzi antigens.
Tadokoro CE; de Almeida Abrahamsohn I
Immunol Lett; 2001 May; 77(1):31-8. PubMed ID: 11348667
[TBL] [Abstract][Full Text] [Related]
57. Effect of in vivo administration of cisplatin on the colony forming ability of murine bone marrow cells.
Kumar R; Sodhi A; Singh SM
Int J Immunopharmacol; 1993 Apr; 15(3):281-6. PubMed ID: 8505139
[TBL] [Abstract][Full Text] [Related]
58. Effects of granulocyte-macrophage colony stimulating factor (GM-CSF) in vivo on cytokine production and proliferation by spleen cells.
Khatami S; Brummer E; Stevens DA
Clin Exp Immunol; 2001 Aug; 125(2):198-201. PubMed ID: 11529909
[TBL] [Abstract][Full Text] [Related]
59. Functional characterization of NK1.1 + Ly-6C+ cells.
Sato N; Yahata T; Santa K; Ohta A; Ohmi Y; Habu S; Nishimura T
Immunol Lett; 1996 Dec; 54(1):5-9. PubMed ID: 9030975
[TBL] [Abstract][Full Text] [Related]
60. Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor.
Gajewski TF; Goldwasser E; Fitch FW
J Immunol; 1988 Oct; 141(8):2635-42. PubMed ID: 2971726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
